Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1999-6-22
|
pubmed:abstractText |
Antiarrhythmic drug therapy still remains the mainstay in the management of many supraventricular and ventricular arrhythmias. Several studies have recently pointed out the role of orally administered class 1C drugs in terminating atrial fibrillation. These drugs can play an important role in the ambulatory management of selected patients. The electrophysiologic mechanisms of these antiarrhythmic drugs together with their pharmacologic properties and clinical indications are discussed according to the current literature.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0268-4705
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
4-8
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9932201-Administration, Oral,
pubmed-meshheading:9932201-Anti-Arrhythmia Agents,
pubmed-meshheading:9932201-Arrhythmias, Cardiac,
pubmed-meshheading:9932201-Atrial Fibrillation,
pubmed-meshheading:9932201-Flecainide,
pubmed-meshheading:9932201-Humans,
pubmed-meshheading:9932201-Propafenone
|
pubmed:year |
1999
|
pubmed:articleTitle |
The role of oral 1C antiarrhythmic drugs in terminating atrial fibrillation.
|
pubmed:affiliation |
Divisione di Cardiologia, Ospedale Civile di Piacenza, Italy.
|
pubmed:publicationType |
Journal Article,
Review
|